Tyrosine Kinase Inhibitors EGFR FGF Serine-Threonine Kinase Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy | Colorectal Cancer | HER2 Positive Breast Cancer | Head and Neck Cancer | Hepatocellular Cancer |
---|---|---|---|---|
regorafenib | ||||
trastuzumab | ||||
cetuximab | ||||
lenvatinib | ||||
sorafenib | ||||
bevacizumab + atezolizumab |